Overview of SARS-COV-2 infection at the Butantan Penitentiary Progression Center

被引:1
|
作者
Andrade, Soraya Gomes de Amorim [1 ]
Andrade, Fernando Moreira [1 ]
da Silva, Anderson [2 ]
Cardoso, Maria Regina Alves [3 ]
Ferraz, Guilherme Rodrigues [2 ]
de Barros, Eliana Nogueira Castro [2 ]
Braga, Patricia Emilia [2 ]
Cristofalo, Milena Martello [1 ,4 ,6 ]
Vieira, Julia Rabello Guerra [4 ]
Lopes, Carolina de Souza [5 ]
Niyama, Alyne [4 ]
de Carvalho, Juliana Lima [4 ]
Aldrighi, Jose Mendes [1 ]
机构
[1] Univ Sao Paulo, Fac Saude Publ, Dept Saude Ciclos Vida & Soc, Sao Paulo, SP, Brazil
[2] Inst Butantan, Sao Paulo, SP, Brazil
[3] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, SP, Brazil
[4] Santa Casa Sao Paulo, Fac Ciencias Med, Sao Paulo, SP, Brazil
[5] Ctr Univ Sao Camilo, Fac Med, Sao Paulo, SP, Brazil
[6] Univ Sao Paulo, Fac Saude Publ, Ave Doutor Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil
来源
REVISTA DE SAUDE PUBLICA | 2023年 / 57卷
关键词
Prisoners; SARS-CoV-2; COVID-19; Testing; Risk Factors; Prevalence; Prisons; CORONAVIRUS DISEASE 2019; COVID-19; PRISON; HEALTH; CITY;
D O I
10.11606/s1518-8787.2023057004717
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE: To estimate the prevalence of exposure to the SARS-CoV-2 virus among individuals living in restricted freedom.METHODS: A seroprevalence survey was carried out with the population of the female penitentiary of the Centro de Progressao Penitenciaria (CPP) in Butantan (municipality of Sao Paulo), between June 24 and August 20, 2020. During this period, according to the Secretariat of Penitentiary Administration (SAP), the positivity of rapid tests among inmates ranged from 65% to 78%. The evaluation method used in the study was the "One Step COVID-19" rapid test (chromatography), from the company Wondfo, also using the RT-PCR method in symptomatic participants to confirm the viral condition. The study population consisted of 879 female inmates and 170 employees of the institution.RESULTS: The prevalence of total antibodies (IgG/IgM) against the SARS-CoV-2 virus in the total population of 1049 study participants was 6.1%; among the population of 879 inmates, a prevalence of 5.8% was observed, and among the institution's employees, 7.5%.CONCLUSIONS: The prevalence of covid-19 at the Butantan CPP was low, which is due to the implementation of simple prevention measures at the institution, such as the use of mask s (with appropriate changes), emphasis on hygiene, hand washing and social distancing, in addition to other strategies, such as suspending inmates' visits from relatives and friends and cutting back on elective medical appointments and outside work.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Assessment and management of the SARS-CoV-2 infection: A secondary center experience
    Yardimci, Cem
    Ergen, Erdem
    Yildiz, Serkan
    Balli, Hatice
    Yildiz, Elif
    Guner, Yasemin Seckin
    Karnap, Muzaffer
    Keskin, Duygu Demirbas
    Yuksel, Hulya
    Bocutoglu, Fusun
    Akbel, Veysel
    Kalyoncu, Derya
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2022, 13 (03): : 309 - 313
  • [22] An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants
    Kayesh, Mohammad Enamul Hoque
    Kohara, Michinori
    Tsukiyama-Kohara, Kyoko
    VIRUSES-BASEL, 2021, 13 (11):
  • [23] Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
    Hromic-Jahjefendic, Altijana
    Lundstrom, Kenneth
    Adilovic, Muhamed
    Aljabali, Alaa A. A.
    Tambuwala, Murtaza M.
    Serrano-Aroca, Angel
    Uversky, Vladimir N.
    AUTOIMMUNITY REVIEWS, 2024, 23 (03)
  • [24] Risk of appendicitis after SARS-CoV-2 infection and SARS-CoV-2 vaccination
    Ljung, Rickard
    Pihlstrom, Nicklas
    Sundstrom, Anders
    BRITISH JOURNAL OF SURGERY, 2022, 109 (08) : 775 - 776
  • [25] SARS-CoV-2 Infection and the Newborn
    Ovali, Fahri
    FRONTIERS IN PEDIATRICS, 2020, 8
  • [26] The Immunopathobiology of SARS-CoV-2 Infection
    Patel, Milankumar
    Shahjin, Farah
    Cohen, Jacob D.
    Hasan, Mahmudul
    Machhi, Jatin
    Chugh, Heerak
    Singh, Snigdha
    Das, Srijanee
    Kulkarni, Tanmay A.
    Herskovitz, Jonathan
    Meigs, Douglas D.
    Chandra, Ramesh
    Hettie, Kenneth S.
    Mosley, R. Lee
    Kevadiya, Bhavesh D.
    Gendelman, Howard E.
    FEMS MICROBIOLOGY REVIEWS, 2021, 45 (06)
  • [27] Neonatal SARS-CoV-2 infection
    de Carvalho, Werther Brunow
    Cicaroni Gibelli, Maria Augusta
    Jornada Krebs, Vera Lucia
    Laurindo Tuma Calil, Valdenise Martins
    Nicolau, Carla Marques
    Johnston, Cintia
    CLINICS, 2020, 75
  • [28] SARS-CoV-2 infection of the placenta
    Hosier, Hillary
    Farhadian, Shelli F.
    Morotti, Raffaella A.
    Deshmukh, Uma
    Lu-Culligan, Alice
    Campbell, Katherine H.
    Yasumoto, Yuki
    Vogels, Chantal B. F.
    Casanovas-Massana, Arnau
    Vijayakumar, Pavithra
    Geng, Bertie
    Odio, Camila D.
    Fournier, John
    Brito, Anderson F.
    Fauver, Joseph R.
    Liu, Feimei
    Alpert, Tara
    Tal, Reshef
    Szigeti-Buck, Klara
    Perincheri, Sudhir
    Larsen, Christopher
    Gariepy, Aileen M.
    Aguilar, Gabriela
    Fardelmann, Kristen L.
    Harigopal, Malini
    Taylor, Hugh S.
    Pettker, Christian M.
    Wyllie, Anne L.
    Dela Cruz, Charles
    Ring, Aaron M.
    Grubaugh, Nathan D.
    Ko, Albert, I
    Horvath, Tamas L.
    Iwasaki, Akiko
    Reddy, Uma M.
    Lipkind, Heather S.
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (09): : 4947 - 4953
  • [29] Propofol and SARS-CoV-2 infection
    Hirota, Kazuyoshi
    Lambert, David G.
    BRITISH JOURNAL OF ANAESTHESIA, 2020, 125 (06) : E475 - E476
  • [30] Immunity to SARS-CoV-2 infection
    Pepper, Marion
    IMMUNOLOGICAL REVIEWS, 2022, 309 (01) : 5 - 7